Internal Medicine, Gastroenterology · Saint Louis, MO
NPI
1326066747
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4921 Parkview Pl, Div Im Gastroenterology, Ste 12b
Saint Louis, MO, 63110
Phone (314) 747-2066
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
446 services
Medicare patients, 2024
307
Average age 68
Drug cost, 2024
$1.1M
2,521 prescriptions
Company payments, 2025
$0
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin M Korenblat was code 99214 (office e&m - established), 195 times for 185 patients. In total Kevin M Korenblat billed 446 services in 23 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 195 | 185 | $84.12 | $16K |
| 99232 Hospital E&M - Subsequent | Facility | 57 | 28 | $59.21 | $3,375 |
| 99222 Hospital E&M - Initial | Facility | 37 | 37 | $100.12 | $3,704 |
| 99205 Office E&M - New | Office | 27 | 27 | $160.31 | $4,328 |
| 91200 Standard X-ray | Office | 27 | 27 | $21.47 | $580 |
| 43239 Upper GI Endoscopy | Facility | 20 | 19 | $69.54 | $1,391 |
| 43235 Upper GI Endoscopy | Facility | 16 | 14 | $73.23 | $1,172 |
| 45380 Lower GI Endoscopy - Other | Facility | 11 | 11 | $117.90 | $1,297 |
By year: 2022 $49K for 664 services; 2023 $49K for 582 services; 2024 $39K for 446 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin M Korenblat prescribed most often to Medicare patients was Tacrolimus, with 455 prescriptions and refills. In total Kevin M Korenblat wrote 2,521 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tacrolimus Generic | 455 | 760 | 86 | $51K |
| Ursodiol Generic | 292 | 517 | 58 | $45K |
| Mycophenolic Acid Mycophenolate Sodium | 137 | 221 | 30 | $25K |
| Xifaxan Rifaximin | 109 | 109 | 14 | $378K |
| Carvedilol Generic | 106 | 166 | 26 | $449 |
| Furosemide Generic | 101 | 204 | 31 | $400 |
| Mycophenolate Mofetil Generic | 95 | 123 | 14 | $4,416 |
| Entecavir Generic | 93 | 155 | 14 | $30K |
| Spironolactone Generic | 93 | 179 | 26 | $854 |
| Prednisone Generic | 84 | 133 | 23 | $552 |
| Azathioprine Generic | 82 | 187 | 21 | $2,882 |
| Lactulose Generic | 77 | 104 | 17 | $4,489 |
| Envarsus Xr Tacrolimus | 65 | 75 | 14 | $47K |
| Omeprazole Generic | 63 | 115 | 19 | $736 |
| Pantoprazole Sodium Generic | 55 | 105 | 12 | $690 |
Brand drugs: - claims; generic drugs: 2,184 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin M Korenblat $0 (- in general payments such as food, travel and fees) from 2 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.